Skip to content

Lucid Group, Inc. LCID Number of Exercisable Options

Number of Exercisable Options at other companies

Bicara Therapeutics logo
Bicara TherapeuticsBCAX
3.3M+87.1%
Imax logo
ImaxIMAX
1.7M-13.2%
First Busey Corporation logo
First Busey CorporationBUSE
9.8K-35.0%
Quantum Computing Inc. logo
Quantum Computing Inc.QUBT
3.8M-62.4%
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
4.5M+12.3%
PBH
Prestige Consumer HealthcarePBH
339.6K-2.9%

Other financials

Income statement

See full
Revenue$282.5M+20.2%
Gross profit-$311.7M-36.4%
Operating income-$989.5M-43.0%
Net income-$1.0B-181%
EPS (diluted)-$3.46-43.6%

Balance sheet

See full
Cash & equivalents$765.7M-58.7%
Total debt$3.9B+51.5%
Total equity-$351.4M-111%
Total assets$7.5B-18.8%

Cash flow

See full
Operating cash flow-$1.2B-177%
CapEx$253.2M+57.0%
Free cash flow-$1.4B-144%

Valuation

See full
Market cap$2.03B-57.4%
Enterprise value$5.14B-22.5%
P/S1.5×-4.0×

Profitability

See full
Gross margin-95.6%-8.3pp
Operating margin-271.1%-46.9pp
Net margin-239.8%-27.6pp
FCF margin-331.8%+13.5pp

Returns & leverage

See full
Return on equity-117.6%+947pp
Debt / equity5.4×+4.8×
Current ratio-2.3×

Where this comes from

Reported directly by Lucid Group, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber.

The official record: Lucid Group, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lucid Group, Inc.'s number of exercisable options.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lucid Group, Inc.'s number of exercisable options?
Lucid Group, Inc. (LCID) reported number of exercisable options of 1.6M in Q1 2026.
How has Lucid Group, Inc.'s number of exercisable options changed year-over-year?
Lucid Group, Inc.'s number of exercisable options decreased by 93.6% year-over-year, from 24.5M to 1.6M.
What does number of exercisable options mean?
The number of share-based payment options that have met all vesting requirements and are currently eligible for exercise by the holders. This represents the portion of the equity incentive pool that could be converted into common stock immediately. It is a critical component for calculating fully diluted share counts.